Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study

Authors :: Heijde, D.
Tanaka, Y.
Fleischmann, R. M.
Keystone, E.
Kremer, J. M.
Zerbini, C.
Cardiel, M. H.
Cohen, S. B.
Nash, P. T.
Song, Y.
Dana Tegzova
Wyman, B.
Gruben, D.
Benda, B.
Wallenstein, G.
Krishnaswami, S.
Zwillich, S. H.
Bradley, J.
Connell, C. A.
Oral, Scan Investigators
Source :: Arthritis and Rheumatism, 64(10), S546-S547, ResearcherID
Publication Year :: 2012

Tools